37.79€
-0.37€ (-0.98%)
End-of-day quote: 04/25/2024
XTRA:FME
Fresenius Medical Care AG & Co. KGaA Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $733.51 | $636.99 | 0.00% | 9 | $654.24B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $146.14 | $174.55 | 0.00% | 3 | $356.43B |
| MRK | Merck | NYSE | Outperform | $131.20 | $130.51 | 0.00% | 11 | $321.69B |
| ABBV | AbbVie | NYSE | Outperform | $159.62 | $178.42 | 0.00% | 11 | $296.21B |
| AZN | AstraZeneca PLC | LSE | Outperform | £119.88 | £165.99 | 0.00% | 16 | £186.43B |
| NOVN | Novartis | SWX | Hold | CHF89.50 | CHF105.00 | 0.00% | 9 | CHF181.47B |
| ROG | Roche Holding | SWX | Hold | CHF221.00 | CHF307.83 | 0.00% | 9 | CHF178.76B |
| DHR | Danaher | NYSE | Outperform | $246.58 | $260.33 | 0.00% | 4 | $182.06B |
| GE | General Electric | NYSE | Outperform | $162.35 | $144.00 | 0.00% | 3 | $177.71B |
| PFE | Pfizer | NYSE | Outperform | $25.40 | $32.87 | 0.00% | 6 | $147.23B |
| AMGN | Amgen | NasdaqGS | Outperform | $269.98 | $303.65 | 0.00% | 8 | $144.81B |
| SYK | Stryker Corp | NYSE | Outperform | $335.61 | $353.16 | 0.00% | 24 | $123.75B |
| SAN | Sanofi | ENXTPA | Outperform | 91.23€ | 102.80€ | 0.00% | 9 | 109.51€B |
| BSX | Boston Scientific | NYSE | Outperform | $73.17 | $70.14 | 0.00% | 6 | $107.55B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.85 | $58.15 | 0.00% | 10 | $90.60B |
| GSK | GSK | LSE | Outperform | £16.53 | £17.30 | 0.00% | 12 | £67.54B |
| 6501 | Hitachi | TSE | Outperform | ¥13.48k | ¥11.29k | 0.00% | 0 | ¥12.49T |
| MRK | Merck KGaA | XTRA | Outperform | 151.75€ | 190.06€ | 0.00% | 4 | 63.48€B |
| BDX | Becton Dickinson and Co | NYSE | Outperform | $231.55 | $284.47 | 0.00% | 8 | $67.64B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.09k | ¥4.74k | 0.00% | 0 | ¥6.38T |
| BIIB | Biogen | NasdaqGS | Outperform | $208.90 | $299.62 | 0.00% | 13 | $29.36B |
| CERN | Cerner | NasdaqGM | - | $94.92 | $95.00 | 0.00% | 0 | $27.92B |
| SIEMENS | Siemens | NSEI | Outperform | Rp5.75k | Rp4.02k | 0.00% | 0 | Rp1.99T |
| 4543 | Terumo | TSE | Outperform | ¥5.63k | ¥4.97k | 0.00% | 0 | ¥3.76T |
| BAX | Baxter International Inc | NYSE | Outperform | $40.13 | $44.86 | 0.00% | 5 | $20.10B |
| PHIA | Koninklijke Philips N.V. | ENXTAM | Hold | 19.75€ | 19.42€ | 0.00% | 9 | 17.09€B |
| HOLX | Hologic | NasdaqGS | Outperform | $75.98 | $81.06 | 0.00% | 3 | $17.77B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $13.81 | $11.59 | 0.00% | 9 | $14.57B |
| INCY | Incyte | NasdaqGS | Outperform | $51.68 | $77.05 | 0.00% | 8 | $11.75B |
| DVA | DaVita Inc | NYSE | Hold | $133.51 | $108.38 | 0.00% | 1 | $11.21B |
| SN. | Smith & Nephew | LSE | Outperform | £9.81 | £16.09 | 0.00% | 10 | £8.41B |
| 3402 | Toray Industries | TSE | Outperform | ¥693.90 | ¥891.82 | 0.00% | 0 | ¥1.15T |
| GETI B | Getinge AB | OM | Outperform | kr235.10 | kr226.10 | 0.00% | 3 | kr64.03B |
| APLS | Apellis Pharmaceuticals | NasdaqGS | Outperform | $49.86 | $79.81 | 0.00% | 3 | $5.73B |
| APN | Aspen Pharmacare Holdings | JSE | Outperform | R220.71 | R202.49 | 0.00% | 1 | R96.56B |
| 1066 | Shandong Weigao Group Medical ... | SEHK | Outperform | HK$5.10 | HK$11.68 | 0.00% | 2 | HK$21.44B |
| EKTA B | Elekta AB (publ) | OM | Hold | kr75.60 | kr83.00 | 0.00% | 1 | kr28.45B |
| 8086 | Nipro | TSE | Hold | ¥1.19k | ¥0.00 | 0.00% | 0 | ¥174.02B |
| MNK | Mallinckrodt | OTCPK | - | $0.08 | $1.50 | 0.00% | 0 | $1.02B |
| MD | Pediatrix Medical Group | NYSE | Hold | $9.04 | $9.86 | 0.00% | 7 | $775.27M |
| 6376 | Nikkiso | TSE | - | ¥1.24k | ¥900.00 | 0.00% | 0 | ¥75.45B |
| AKBA | Akebia Therapeutics | NasdaqCM | Outperform | $1.34 | $4.33 | 0.00% | 2 | $305.19M |
| OMER | Omeros | NasdaqGM | Hold | $3.15 | $13.00 | 0.00% | 2 | $282.89M |
| XFOR | X4 Pharmaceuticals | NasdaqCM | Outperform | $1.17 | $3.26 | 0.00% | 1 | $158.26M |
| 4538 | Fuso Pharmaceutical Industries... | TSE | - | ¥2.23k | ¥0.00 | 0.00% | 0 | ¥18.38B |
| DXB | Dimerix | ASX | $0.32 | $0.00 | 0.00% | 0 | $159.38M | |
| 7702 | JMS | TSE | - | ¥519.00 | ¥0.00 | 0.00% | 0 | ¥15.03B |
| IFRX | InflaRx N.V. | NasdaqGS | Outperform | $1.33 | $9.44 | 0.00% | 2 | $79.49M |
| BLRX | BioLineRx | TASE | - | ₪0.17 | ₪1.39 | 0.00% | 0 | ₪302.07M |
| CTSO | Cytosorbents | NasdaqCM | Outperform | $0.82 | $4.50 | 0.00% | 1 | $52.73M |
| NEPH | Nephros | NasdaqCM | Buy | $2.19 | $4.50 | 0.00% | 0 | $31.66M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.19 | $80.00 | 0.00% | 0 | $9.43M |
| AKSY | Aksys | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
